ImageneBio (IMA) Current Assets (2020 - 2025)
ImageneBio (IMA) posted Current Assets of $140.3 million for Q4 2025, down 4.91% sequentially from $147.5 million in Q3 2025, and up 1025.18% YoY from $12.5 million in Q4 2024.
ImageneBio (IMA) Current Assets (2020 - 2025) Analysis & Trends
ImageneBio has reported Current Assets for 6 years, with the latest figure at $140.3 million in Q4 2025.
- Quarterly Current Assets rose 1025.18% year-over-year to $140.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $140.3 million (up 1025.18% YoY) and the FY2025 annual result came in at $140.3 million, up 1025.18% from the prior year.
- Current Assets eased to $140.3 million in Q4 2025 per IMA's latest filing, from $147.5 million in the prior quarter.
- Over five years, Current Assets peaked at $283.2 million in Q1 2021 and troughed at $12.5 million in Q4 2024.
- A 5-year average of $172.1 million and a median of $160.9 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets tumbled 93.02% in 2024, then soared 1025.18% in 2025.
- Over 5 years, Current Assets stood at $236.5 million in 2021, then sank by 32.35% to $160.0 million in 2022, then gained by 11.66% to $178.7 million in 2023, then sank by 93.02% to $12.5 million in 2024, then jumped by 1025.18% to $140.3 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $140.3 million, $147.5 million, and $99.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.88 Bn | 132.03 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.62 Bn | 78.62 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.10 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 61.39 Bn | 56.25 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.37 Bn | 28.06 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.76 Bn | 10.37 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 1.76 Bn |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - | 140.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 140.29 Mn |
| Sep 30, 2025 | 147.53 Mn |
| Jun 30, 2025 | 99.01 Mn |
| Mar 31, 2025 | 117.00 Mn |
| Dec 31, 2024 | 12.47 Mn |
| Sep 30, 2024 | 141.53 Mn |
| Jun 30, 2024 | 149.32 Mn |
| Mar 31, 2024 | 161.17 Mn |
| Dec 31, 2023 | 178.66 Mn |
| Sep 30, 2023 | 200.63 Mn |
| Jun 30, 2023 | 160.65 Mn |
| Mar 31, 2023 | 141.18 Mn |
| Dec 31, 2022 | 160.01 Mn |
| Sep 30, 2022 | 177.98 Mn |
| Jun 30, 2022 | 199.15 Mn |
| Mar 31, 2022 | 216.05 Mn |
| Dec 31, 2021 | 236.52 Mn |
| Sep 30, 2021 | 251.87 Mn |
| Jun 30, 2021 | 268.71 Mn |
| Mar 31, 2021 | 283.23 Mn |